NAT10 and rheumatoid arthritis: Secondly, our study only recruited 20 patients with RA and 16 patients with SLE as autoimmune disease control may limit value of the predictive model based on mRNA NAT10 and N% in real clinical practice, due to N% also significantly rises in other inflammatory diseases excepts AS, RA, SLE.